Michael Thomas Heffernan - 10 Feb 2025 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role: Director
Signature: /s/ Shirley R. Kuhlmann as Attorney-in-Fact for Michael T. Heffernan
Issuer symbol: COLL
Transactions as of: 10 Feb 2025
Net transactions value: $0
Form type: 4
Filing time: 12 Feb 2025, 16:10:53 UTC
Previous filing: 14 Jun 2024
Next filing: 26 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COLL	Common Stock	Award	$0	+4,820	+11%	$0.000000	50,328	10 Feb 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the grant of fully-vested restricted stock units ("RSUs") granted as compensation for the Reporting Person's service as interim Chief Executive Officer in 2024. Each RSU represents a contingent right to receive one share of the Issuer's common stock.